Zynext Ventures

Zynext Ventures is the Venture Capital arm of the global pharmaceutical company Zydus Lifesciences. We are a 'New-age' venture capital firm investing in seed and early-stage disruptive biotech and healthcare technologies that have the potential to tackle significant unmet needs in the healthcare space. We recognize a significant convergence in the current landscape of healthcare, where sophisticated data processing technologies such as Artificial Intelligence and Machine Learning are fundamentally transforming the paradigms of disease diagnosis, treatment, and prevention. At Zynext, we aim to be at the forefront of this revolution by backing innovators who are making this happen. Embracing the profound expertise and industry acumen passed down from our parent company, Zydus Lifesciences, we offer more than mere capital. We are the trailblazers, illuminating the path for translational research, charting strategic courses to commercialization, unveiling avenues for strategic acquisitions, providing world-class guidance, and unlocking the doors to cutting-edge industrial infrastructure. At Zynext Ventures, we are not mere investors; we are the catalysts of success.